Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-01-14

Clinical Trial Update: The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two Traditional Chinese Medicines for clozapine-induced hypersalivation in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Schizophrenia, Clozapine | Phase 2 | Status: UNKNOWN